Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AI Unlimited Group’s Lever App Seizes Opportunity to Revolutionize Student Loan Servicing in Wake of CFPB Report
-
Hope on the Horizon: Nephrologists Emphasize Need for Innovative C3G Treatments as Novartis and Apellis Prepare Therapies for FDA Submission
-
Malaga Financial Corporation Announces Special Year-End 2024 Stock Dividend in Addition to First Quarter 2025 Cash Dividend
-
REMSleep Holdings, Inc. Shareholder Update
-
H&E Rentals Reports Quarterly Cash Dividend
-
Unwrap the Savings: Expert Tips on the Best Ways to Save this Holiday Shopping Season
-
United Steelworkers union and University of Toronto launch new research chair honouring Leo Gerard
-
Transaction in Own Shares
-
Ranchero Announces Debt Settlement Transaction
-
Hermès International: Shares and voting rights as of 31 October 2024
-
Veteran SaaS Marketing Executive to Drive Revenue Growth and Scale Operations for Chief Outsiders Clients
-
Edmontonians cycle for kids at The Y Ride fundraising event
-
YMCA of Northern Alberta Research Underway in Edmonton
-
Lieutenant Governor Aruna Miller and Secretary Carol Beatty Join SCI Day to Celebrate Community Impact
-
Press release: Orange contests the measures taken by the PNF concerning a VAT allocation dispute for 2017-2019
-
Bybit Expands bbSOL Yield Opportunities Through Strategic DeFi Partnerships
-
Voluntary Public Tender and Exchange Offer for all the Shares of Unieuro - supplemental information on the procedure
-
Bouygues Telecom acquires the MVNO La Poste Mobile and announces an exclusive distribution agreement with La Poste group
-
Information on the date of the next Annual General Meeting of Renault S.A.
-
Director/PDMR Shareholding
-
Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update
-
Issue of Equity - DRIS
-
Allsup Names David Doeren President And Chief Operating Officer, Strengthening Leadership For Future Growth
-
Domino’s Pizza (NYSE: DPZ) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
-
OFFER UPDATE – USE OF OVER-ALLOTMENT FACILITY
-
Ress Life Investments A/S: Ress Life Investments A/S publishes Net Asset Value (NAV).
-
Kalmar Corporation: Share Repurchase 15.11.2024
-
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 15 November 2024
-
Metania Games: Redefining Blockchain Gaming with Innovation and Engagement
-
The Southern Banc Company, Inc. Announces First Quarter Earnings
-
Alma íbúðafélag hf.: Lækkun skuldabréfaútgáfu AL260148.
-
From One Truck to Industry Titan: Saia LTL Freight Celebrates 100 Years
-
Results of General Meeting, Merger and Share Redesignation
-
Merger Results and Redesignation of Shares
-
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
-
Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
-
Dawn Project testing of Tesla Full Self-Driving vindicated by Tesla supporter
-
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
-
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
-
Bluejay Therapeutics Reports Best-in-Class Monoclonal Antibody BJT-778 Achieved 100% Virologic Response and Up To 78% Combined Virologic Response and ALT Normalization as Monotherapy in Participants W
-
Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
-
Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024
-
Eccogene Announces Positive Phase 1 Data for Oral THR-β Full Agonist and Oral SSAO Inhibitor in Late-Breaking Poster Presentations at the American Association for the Study of Liver Diseases (AASLD)
-
Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
-
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
-
CoinShares Showcases Strategic Excellence Through Successful Transformation of Valkyrie Business
-
Azuria Water Solutions Announces Acquisition of North American Pipeline Management, Inc.
-
Kelly Named Corporation of the Year by National Minority Supplier Development Council
-
Florida Bank CEOs and Civic Leaders Convene to Address Affordable Housing
-
Bike New York & Let’s Do This Announce New Partnership to Enhance Registration Experience for Riders

